The price of Atyr Pharma Inc (NASDAQ: LIFE) closed at $1.79 in the last session, down -6.28% from day before closing price of $1.91. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 956937 shares were traded.
Ratios:
We take a closer look at LIFE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.33 and its Current Ratio is at 8.33. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.14.
On October 12, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $22.
On September 21, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $19.Piper Sandler initiated its Overweight rating on September 21, 2021, with a $19 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 06 when Broadfoot Jill Marie sold 1,590 shares for $1.69 per share. The transaction valued at 2,687 led to the insider holds 20,821 shares of the business.
Shukla Sanjay bought 12,000 shares of LIFE for $14,136 on Dec 12. The President and CEO now owns 106,173 shares after completing the transaction at $1.18 per share. On Dec 11, another insider, Shukla Sanjay, who serves as the President and CEO of the company, bought 3,000 shares for $1.17 each. As a result, the insider paid 3,510 and bolstered with 94,173 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIFE now has a Market Capitalization of 111.85M and an Enterprise Value of 24.94M. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.76 while its Price-to-Book (P/B) ratio in mrq is 1.07. Its current Enterprise Value per Revenue stands at 2.32 whereas that against EBITDA is -0.57.
Stock Price History:
Over the past 52 weeks, LIFE has reached a high of $2.70, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 1.6593, while the 200-Day Moving Average is calculated to be 1.7141.
Shares Statistics:
According to the various share statistics, LIFE traded on average about 537.75K shares per day over the past 3-months and 753.59k shares per day over the past 10 days. A total of 58.56M shares are outstanding, with a floating share count of 56.48M. Insiders hold about 3.56% of the company’s shares, while institutions hold 69.93% stake in the company. Shares short for LIFE as of Feb 15, 2024 were 135.28k with a Short Ratio of 0.25, compared to 177.45k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.23% and a Short% of Float of 0.34%.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.21 and a low estimate of -$0.28, while EPS last year was -$0.26. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.18 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.91 and -$0.97 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$0.85, with 5 analysts recommending between -$0.56 and -$0.99.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for LIFE’s current fiscal year. The highest revenue estimate was $600k, while the lowest revenue estimate was $350k, resulting in an average revenue estimate of $410k. In the same quarter a year ago, actual revenue was $10.39M, down -96.10% from the average estimate.
